What one share of Harmony Biosciences Holdings holds
We are cultivating a differentiated neuroscience company, rooted in innovation and driven by a commitment to addressing the unmet needs of patients living with neurological diseases. To date, we have focused on rare neurological diseases with a growing portfolio now spanning sleep/wake, rare epilepsy, and neurobehavioral and we are harnessing scientific insights and pioneering approaches to advance meaningful treatments that help patients thrive.
Harmony Biosciences Holdings’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $16.35 |
|---|---|
| Profit | $3.09 |
| Cash and investments | $9.46 |
| Debt | $2.65 |
| Book value | $17.19 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2019 | $0.77 | −$24.07 | $0.02 | −$9.72 | — | −$54.30 |
| 2020 | $6.20 | −$2.48 | $0.00 | −$0.12 | — | — |
| 2021 | $5.16 | $0.58 | $0.01 | $1.66 | — | $3.17 |
| 2022 | $7.17 | $2.97 | $0.00 | $2.36 | — | $6.76 |
| 2023 | $9.64 | $2.13 | $0.01 | $3.63 | — | $8.23 |
| 2024 | $12.35 | $2.51 | $0.02 | $3.78 | — | $11.53 |
| 2025 | $14.83 | $2.71 | $0.01 | $5.94 | — | $15.07 |
Common questions about Harmony Biosciences Holdings
How much does one share of Harmony Biosciences Holdings earn?
Over the last 12 months, each share of Harmony Biosciences Holdings earned $3.09 of profit on $16.35 of sales, keeping about 19¢ of every $1 (profit margin).
Does Harmony Biosciences Holdings pay a dividend?
Harmony Biosciences Holdings didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Harmony Biosciences Holdings’s book value per share?
Harmony Biosciences Holdings’s book value is $17.19 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Harmony Biosciences Holdings have?
Each share of Harmony Biosciences Holdings has $9.46 of cash and investments and $2.65 of debt, as of June 30, 2026.
Has Harmony Biosciences Holdings bought back shares?
Harmony Biosciences Holdings’s share count rose about 653% from 2019 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.